Skandinaviska Enskilda Banken AB publ Has $12.79 Million Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Skandinaviska Enskilda Banken AB publ increased its position in Mettler-Toledo International Inc. (NYSE:MTD) by 77.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,485 shares of the medical instruments supplier’s stock after buying an additional 4,581 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Mettler-Toledo International were worth $12,791,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MTD. State Street Corp boosted its holdings in Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after acquiring an additional 9,009 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after purchasing an additional 4,166 shares in the last quarter. Principal Financial Group Inc. grew its position in Mettler-Toledo International by 13.9% in the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares during the period. Barclays PLC increased its stake in Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Citigroup reduced their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Evercore ISI lifted their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Finally, Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and an average price target of $1,380.50.

Mettler-Toledo International Trading Up 2.4 %

MTD stock opened at $1,231.32 on Friday. The stock’s fifty day simple moving average is $1,295.03 and its two-hundred day simple moving average is $1,318.19. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93. The stock has a market cap of $25.75 billion, a P/E ratio of 30.38, a P/E/G ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the company’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now owns 734 shares of the company’s stock, valued at $964,248.46. This represents a 51.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gerry Keller sold 600 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now directly owns 6 shares in the company, valued at $8,108.04. This represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.